-
Signature
-
/s/ Joshua F. Patterson, Attorney-in-Fact for James J. Mulay
-
Issuer symbol
-
CGON
-
Transactions as of
-
09 Jan 2026
-
Net transactions value
-
-$450,284
-
Form type
-
4
-
Filing time
-
13 Jan 2026, 16:15:07 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Mulay James |
Director |
C/O CG ONCOLOGY, INC., 400 SPECTRUM CENTER DRIVE, SUITE 2040, IRVINE |
/s/ Joshua F. Patterson, Attorney-in-Fact for James J. Mulay |
13 Jan 2026 |
0001684531 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CGON |
Common Stock |
Options Exercise |
$2,433 |
+654 |
|
$3.72 |
654 |
09 Jan 2026 |
Direct |
|
| transaction |
CGON |
Common Stock |
Sale |
$28,881 |
-654 |
-100% |
$44.16 |
0 |
09 Jan 2026 |
Direct |
F1 |
| transaction |
CGON |
Common Stock |
Options Exercise |
$132,082 |
+10,491 |
|
$12.59 |
10,491 |
09 Jan 2026 |
Direct |
|
| transaction |
CGON |
Common Stock |
Sale |
$555,918 |
-10,491 |
-100% |
$52.99 |
0 |
09 Jan 2026 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CGON |
Director Stock Option (right to buy) |
Options Exercise |
$0 |
-654 |
-33% |
$0.000000 |
1,308 |
09 Jan 2026 |
Common Stock |
654 |
$3.72 |
Direct |
F2 |
| transaction |
CGON |
Director Stock Option (right to buy) |
Options Exercise |
$0 |
-10,491 |
-67% |
$0.000000 |
5,240 |
09 Jan 2026 |
Common Stock |
10,491 |
$12.59 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: